Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Zhang W, Xing SS, Wang HJ, Xing QC. Fixed-dose single tablet combinations: an alternative for initial therapy of patients with type 2 diabetes? Curr Med Res Opin 2011;27:2321-2. [PMID: 22040083 DOI: 10.1185/03007995.2011.628306] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]

For:	Zhang W, Xing SS, Wang HJ, Xing QC. Fixed-dose single tablet combinations: an alternative for initial therapy of patients with type 2 diabetes? Curr Med Res Opin 2011;27:2321-2. [PMID: 22040083 DOI: 10.1185/03007995.2011.628306] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]

Number	Cited by Other Article(s)
1	Lajara R. Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes. Expert Opin Pharmacother 2012;13:2663-71. [DOI: 10.1517/14656566.2012.741591] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Lajara R. Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes. Expert Opin Pharmacother 2012;13:2663-71. [DOI: 10.1517/14656566.2012.741591] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]